Abstract:Background and objectives: Encephalitis is a devastating neurologic disorder with high morbidity and mortality. Autoimmune causes are roughly as common as infectious ones. N-methyl-D-aspartic acid receptor (NMDAR) encephalitis (NMDARE), characterized by serum and/or spinal fluid NMDAR antibodies, is the most common form of autoimmune encephalitis (AE). A translational rodent NMDARE model would allow for pathophysiologic studies of AE, leading to advances in the diagnosis and treatment of this debilitating neuropsychiatric disorder. The main objective of this work was to identify optimal active immunization conditions for NMDARE in mice. Methods: Female C57BL/6J mice aged 8 weeks old were injected subcutaneously with an emulsion of complete Freund's adjuvant, killed and dessicated Mycobacterium tuberculosis, and a 30 amino acid peptide flanking the NMDAR GluN1 subunit N368/G369 residue targeted by NMDARE patients' antibodies. Three different induction methods were examined using subcutaneous injection of the peptide emulsion mixture into mice in 1) the ventral surface, 2) the dorsal surface, or 3) the dorsal surface with reimmunization at 4 and 8 weeks (boosted). Mice were bled biweekly and sacrificed at 2, 4, 6, 8, and 14 weeks. Serum and CSF NMDAR antibody titer, mouse behavior, hippocampal cell surface and postsynaptic NMDAR cluster density, and brain immune cell entry and cytokine content were examined. Results: All immunized mice produced serum and CSF NMDAR antibodies, which peaked at 6 weeks in the serum and at 6 (ventral and dorsal boosted) or 8 weeks (dorsal unboosted) post-immunization in the CSF, and demonstrated decreased hippocampal NMDAR cluster density by 6 weeks post-immunization. In contrast to dorsally-immunized mice, ventrally-induced mice displayed a translationally-relevant phenotype including memory deficits and depressive behavior, changes in cerebral cytokines, and entry of T-cells into the brain at the 4-week timepoint. A similar phenotype of memory dysfunction and anxiety was seen in dorsally-immunized mice only when they were serially boosted, which also resulted in higher antibody titers. Discussion: Our study revealed induction method-dependent differences in active immunization mouse models of NMDARE disease. A novel ventrally-induced NMDARE model demonstrated characteristics of AE earlier compared to dorsally-induced animals and is likely suitable for most short-term studies. However, boosting and improving the durability of the immune response might be preferred in prolonged longitudinal studies.

Animal models of immune-mediated demyelinating polyneuropathies

Immune-Mediated Neuropathies: Pathophysiology and Management

Small fibre integrity and axonal pathology in the rat model of experimental autoimmune neuritis

Development of a major histocompatibility complex class II conditional knockout mouse to study cell‐specific and time‐dependent adaptive immune responses in peripheral nerves

Using EAE to better understand principles of immune function and autoimmune pathology

Scientific issues with rodent models of neuromyelitis optic spectrum disorders

Optimizing animal models of autoimmune encephalitis using active immunization

An Experimental Model of Neuromyelitis Optica Spectrum Disorder-Optic Neuritis: Insights Into Disease Mechanisms

Animal models in myositis

Differential regulation of tissue-resident and blood-derived macrophages in models of autoimmune and traumatic peripheral nerve injury

Advances and challenges in modeling inherited peripheral neuropathies using iPSCs

Dirty Fish Versus Squeaky Clean Mice: Dissecting Interspecies Differences Between Animal Models of Interferonopathy

Dynamics of Production of MIP-1α, MCP-1 and MIP-2 and Potential Role of Neutralization of These Chemokines in the Regulation of Immune Responses During Experimental Autoimmune Neuritis in Lewis Rats

Multiple sclerosis animal models: a clinical and histopathological perspective

Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies

Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease

Low Frequency Ultrasound with Injection of NMO-IgG and Complement Produces Lesions Different from Experimental Autoimmune Encephalomyelitis Mice

Inflammation and Severe Demyelination in the Peripheral Nervous System Induced by the Intraneural Injection of Recombinant Mouse Interleukin-12.

Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic

Overview of emerging therapies for demyelinating diseases

Validating a minipig model of reversible cerebral demyelination using human diagnostic modalities and electron microscopy